NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
$3.24
0.00%
$27.9M
No data for this timeframe.
Vol
Market Cap$27.9M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (89%)
Insider Activity1B / 5S
Insider Net $$647.3K
Reddit Sentiment67° Warm
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001500198·Prev Close $3.24
Recent Activity
Jun 12, 2026
SEC
NeuroOne Medical Technologies filed a prospectus supplement to increase its ATM offering capacity from $8.4M already sol
424B5, 8-K — Impact 6/10
May 22, 2026
SEC
NeuroOne Medical Technologies filed an 8-K announcing a restatement of its Q2 FY2026 financials (quarter ended March 31,
8-K — Impact 7/10
May 12, 2026
SEC
NeuroOne reported fiscal Q2 2026 product revenue of $2.4M (up 72% YoY), narrowing the net loss to $2.1M ($0.25/share) fr
8-K — Impact 6/10
May 12, 2026
earnings_calendar
NMTC Q2 2026 Earnings Scheduled — 2026-05-12
Apr 3, 2026
Insider
Andrle Edward was granted 41,929 shares
Director
Apr 3, 2026
Insider
Andrle Edward was granted 26,036 shares
Director
Apr 3, 2026
Insider
BUCKMAN PAUL was granted 41,929 shares
Director
Price Targets
$9.93
+206.6% upside
Strong Buy
Current $3.24
Low $8.00
Median $8.80
High $13.00
3 analysts
$8.00
$13.00
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 13, 2026 | Ladenburg Thalmann | MAINTAIN | Buy → Buy |
| Mar 2, 2026 | Jones Trading | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.22 ▼ -20.4% | $-0.26 — $-0.17 | -20% YoY | 3 |
| Next Q | $-0.19 ▼ -18.8% | $-0.26 — $-0.15 | 21% YoY | 3 |
| Current FY | $-0.68 ▲ +8.6% | $-0.94 — $-0.35 | -25% YoY | 3 |
| Next FY | $-0.51 ▼ -2.0% | $-0.69 — $-0.29 | 25% YoY | 3 |
Latest Reports
BEARISH
424B5, 8-K
6/10
NeuroOne Medical Technologies filed a prospectus supplement to increase its ATM offering capacity from $8.4M already sol
Jun 12, 2026
BEARISH
8-K
7/10
NeuroOne Medical Technologies filed an 8-K announcing a restatement of its Q2 FY2026 financials (quarter ended March 31,
May 22, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 3, 2026 | Andrle Edward | A | $0.00 |
| Apr 3, 2026 | Andrle Edward | A | $0.00 |
| Apr 3, 2026 | BUCKMAN PAUL | A | $0.00 |
| Apr 3, 2026 | BUCKMAN PAUL | A | $0.00 |
| Apr 3, 2026 | MATHIESEN JEFFREY | A | $0.00 |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
8 unique insiders with 21 transactions. Net insider value: $647.3K ($670.4K bought, $23.1K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 3, 2026 | Andrle Edward | Director | AWARD | 41,929 | — | — |
| Apr 3, 2026 | Andrle Edward | Director | AWARD | 26,036 | — | — |
| Apr 3, 2026 | BUCKMAN PAUL | Director | AWARD | 41,929 | — | — |
| Apr 3, 2026 | BUCKMAN PAUL | Director | AWARD | 26,036 | — | — |
| Apr 3, 2026 | MATHIESEN JEFFREY S | Director | AWARD | 41,929 | — | — |
| Apr 3, 2026 | MATHIESEN JEFFREY S | Director | AWARD | 26,036 | — | — |
| Apr 3, 2026 | Mills Jason Richard | Director | AWARD | 41,929 | — | — |
| Apr 3, 2026 | Mills Jason Richard | Director | AWARD | 26,036 | — | — |
| Mar 31, 2026 | Mertens Steve | Chief Technology Officer | TAX W/H | 906 | $0.7770 | $703.96 |
| Mar 31, 2026 | Christianson Mark | Business Development Director | TAX W/H | 253 | $0.7770 | $196.58 |
| Mar 31, 2026 | Rosa David A | CEO and President | TAX W/H | 2,458 | $0.7770 | $1.9K |
| Mar 30, 2026 | Christianson Mark | Business Development Director | SELL | 15,363 | $0.7400 | $11.4K |
| Mar 13, 2026 | Christianson Mark | Business Development Director | SELL | 100 | $0.8000 | $80.00 |
| Mar 12, 2026 | Christianson Mark | Business Development Director | SELL | 817 | $0.8000 | $653.60 |
| Mar 11, 2026 | Christianson Mark | Business Development Director | SELL | 2,109 | $0.8000 | $1.7K |
| Mar 10, 2026 | Christianson Mark | Business Development Director | SELL | 11,611 | $0.8000 | $9.3K |
| Mar 1, 2026 | Wambeke David J. | Chief Business Officer | BUY | 1,000,000 | $0.6704 | $670.4K |
| Mar 1, 2026 | Wambeke David J. | Chief Business Officer | AWARD | 500,000 | — | — |
| Feb 18, 2026 | Christianson Mark | Business Development Director | TAX W/H | 1,812 | $0.6800 | $1.2K |
| Feb 18, 2026 | Mertens Steve | Chief Technology Officer | TAX W/H | 7,376 | $0.6800 | $5.0K |
| Feb 18, 2026 | Rosa David A | CEO and President | TAX W/H | 71,325 | $0.6800 | $48.5K |
6 SEC filing reports analyzed. Sentiment: 2 bullish, 2 bearish, 0 mixed, 2 neutral. Avg impact: 5.0/10.
BEARISH
424B5, 8-K
6/10
NeuroOne Medical Technologies filed a prospectus supplement to increase its ATM offering capacity fr
Jun 12, 2026
BEARISH
8-K
7/10
NeuroOne Medical Technologies filed an 8-K announcing a restatement of its Q2 FY2026 financials (qua
May 22, 2026
BULLISH
8-K
6/10
NeuroOne reported fiscal Q2 2026 product revenue of $2.4M (up 72% YoY), narrowing the net loss to $2
May 12, 2026
BULLISH
8-K
5/10
NeuroOne Medical Technologies regained compliance with Nasdaq's minimum bid price rule, resolving a
May 4, 2026
NEUTRAL
8-K
3/10
CFO Ronald McClurg is retiring effective June 30, 2026, with COO Christopher Volker succeeding him a
Apr 30, 2026
NEUTRAL
8-K
3/10
NeuroOne Medical Technologies Corporation announced the date for its 2026 annual meeting of stockhol
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$9.93 mean target
+206.6% upside
Strong Buy (3.00)
$8.00 Low
$13.00 High
| Metric | Value |
|---|---|
| Current Price | $3.24 |
| Target Low | $8.00 |
| Target Mean | $9.93 |
| Target Median | $8.80 |
| Target High | $13.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.22 | $-0.26 | $-0.17 | -20.4% | -20.4% | 1↑ 0↓ | $0.0B | 50.2% | 3 |
| Next Q 2026-09-30 |
$-0.19 | $-0.26 | $-0.15 | 20.8% | -18.8% | — | $0.0B | 10.2% | 3 |
| Current FY 2026-09-30 |
$-0.68 | $-0.94 | $-0.35 | -25.3% | +8.6% | 2↑ 0↓ | $0.0B | 19.3% | 3 |
| Next FY 2027-09-30 |
$-0.51 | $-0.69 | $-0.29 | 24.6% | -2.0% | 1↑ 0↓ | $0.0B | 34.3% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.217 | |
| 7d ago | $-0.183 | -0.033 |
| 30d ago | $-0.180 | -0.037 |
| 60d ago | $-0.180 | -0.037 |
| 90d ago | $-0.240 | +0.023 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 13, 2026 | Ladenburg Thalmann | MAINTAIN | Buy | Buy |
| Mar 2, 2026 | Jones Trading | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| May 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 12, 2026
earnings_calendar
NMTC Q2 2026 Earnings Scheduled — 2026-05-12
May 11, 2026
earnings_calendar
NMTC Q2 2026 Earnings Scheduled — 2026-05-11